Medium materiality6/10
Summit Therapeutics price target raised to $20 from $18 at Barclays
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Barclays raises SMMT PT to 20; current price 16.91; price change since signal -1.3.
- PT 20; current 16.91; price -1.3 since signal.
Key facts
- 01
Target: $20
- 02
Posted price: $16.91
- 03
Analyst firm: Barclays
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.